Holobiome, Inc. — Form D
Holobiome, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-28. The offering totals $1.3M, of which $625K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-12-28
- Form: D
- Accession: 0001763027-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $625K
- Remaining: $625K
- Investors: 1
- Date of first sale: 2018-12-17
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-329087
Issuer
- Name: Holobiome, Inc.
- CIK: 0001763027
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 650 ALBANY STREET STE 127, BOSTON, MA, 02118
- Phone: (857) 244-1633
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Phil Strandwitz | Director | Cambridge, MA |
| Phil Strandwitz | Executive Officer | Cambridge, MA |
| Kim Lewis | Director | Chicago, IL |
| Philip Strandwitz | Director | Boston, MA |
| Philip Strandwitz | Executive Officer | Boston, MA |
| Philip Strandwitz | Related Person | Boston, MA |
| Iain Chessell | Director | Boston, MA |
| Iain Chessell | Related Person | Boston, MA |
| Michael LaFleur | Director | Boston, MA |
| Michael LaFleur | Executive Officer | Boston, MA |
| Michael LaFleur | Related Person | Boston, MA |
| Joan LaRovere | Director | Boston, MA |
| Joan LaRovere | Related Person | Boston, MA |
| Ian Chessell | Director | Cambridge, MA |
Other filings by this issuer (3)
More